Encoded Therapeutics

About:

Encoded Therapeutics is a Harnessing the regulatory genome to create next-generation molecular therapies.

Website: https://encoded.com/

Twitter/X: EncodedGenomics

Top Investors: Alexandria Venture Investments, ARCH Venture Partners, Menlo Ventures, Google Ventures, Venrock

Description:

Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad range of severe genetic disorders. The company's therapy pipeline addresses devastating genetic and acquired disorders spanning multiple disease pathways including neurocircuitry, metabolic disorders, neurodegeneration and cardiovascular disease, enabling medical practitioners to treat patients and improve their lives.

Total Funding Amount:

$239M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

South San Francisco, California, United States

Founded Date:

2014-01-01

Contact Email:

info(AT)encodedgenomics.com

Founders:

Kartik Ramamoorthi, Stephanie Tagliatela

Number of Employees:

101-250

Last Funding Date:

2020-07-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai